{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:52:14Z","timestamp":1690545134733},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00059-022-05148-0","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T09:08:54Z","timestamp":1669626534000},"page":"3-14","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Die neue ESC-Leitlinie zum Management ventrikul\u00e4rer Tachyarrhythmien"],"prefix":"10.1007","volume":"48","author":[{"given":"Hilke","family":"K\u00f6nemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Zeppenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"5148_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehac262","volume":"23","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M et al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 23:1\u2013130. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"key":"5148_CR2","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstr\u00f6m-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart\u00a0J 36:2793\u20132867. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"5148_CR3","doi-asserted-by":"crossref","unstructured":"Eckardt L, K\u00f6nemann H, Bosch R et al (2022) Kommentar zu den ESC-Leitlinien 2022 \u201eVentrikul\u00e4re Arrhythmien und Pr\u00e4vention des pl\u00f6tzlichen Herztodes\u201c. Kardiologie (im Druck)","DOI":"10.1007\/s12181-022-00589-7"},{"key":"5148_CR4","unstructured":"Fischer M, Wnent J, Gr\u00e4sner J\u2011T et al (2022) \u00d6ffentlicher Jahresbericht 2021 des Deutschen Reanimationsregisters: Au\u00dferklinische Reanimation 2021. https:\/\/www.reanimationsregister.de\/berichte.html. Zugegriffen: 18. Okt. 2022"},{"key":"5148_CR5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1405796","volume":"372","author":"I Hasselqvist-Ax","year":"2015","unstructured":"Hasselqvist-Ax\u00a0I, Riva\u00a0G, Herlitz\u00a0J et al (2015) Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest. N\u00a0Engl J Med 372:2307\u20132315. https:\/\/doi.org\/10.1056\/NEJMoa1405796","journal-title":"N Engl J Med"},{"key":"5148_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/eurheartj\/ehw230","volume":"38","author":"M Ortiz","year":"2017","unstructured":"Ortiz\u00a0M, Mart\u00edn\u00a0A, Arribas\u00a0F et\u00a0al (2017) Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart\u00a0J 38:1329\u20131335. https:\/\/doi.org\/10.1093\/eurheartj\/ehw230","journal-title":"Eur Heart J"},{"key":"5148_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","volume":"5","author":"A Di Marco","year":"2017","unstructured":"Di Marco\u00a0A, Anguera\u00a0I, Schmitt\u00a0M et al (2017) Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail 5:28\u201338. https:\/\/doi.org\/10.1016\/j.jchf.2016.09.017","journal-title":"JACC Heart Fail"},{"key":"5148_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.hrtlng.2017.10.008","volume":"47","author":"D He","year":"2018","unstructured":"He\u00a0D, Ye\u00a0M, Zhang\u00a0L et\u00a0al (2018) Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Heart Lung 47:122\u2013126. https:\/\/doi.org\/10.1016\/j.hrtlng.2017.10.008","journal-title":"Heart Lung"},{"key":"5148_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","volume":"7","author":"T Crawford","year":"2014","unstructured":"Crawford\u00a0T, Mueller\u00a0G, Sarsam\u00a0S et\u00a0al (2014) Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol 7:1109\u20131115. https:\/\/doi.org\/10.1161\/CIRCEP.113.000156","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"5148_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs\u00a0J (2021) Heart failure drug treatment: the fantastic four. Eur Heart\u00a0J 42:681\u2013683. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1012","journal-title":"Eur Heart J"},{"key":"5148_CR11","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"5148_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","volume":"13","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer\u00a0G, Eckardt\u00a0L (2016) Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol 13:36\u201347. https:\/\/doi.org\/10.1038\/nrcardio.2015.110","journal-title":"Nat Rev Cardiol"},{"key":"5148_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02090-3","author":"L Eckardt","year":"2022","unstructured":"Eckardt\u00a0L, Doldi\u00a0F, Busch\u00a0S et al (2022) 10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-022-02090-3","journal-title":"Clin Res Cardiol"},{"key":"5148_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp\u00a0JL, Wells\u00a0GA, Parkash\u00a0R et\u00a0al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N\u00a0Engl J Med 375:111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1513614","journal-title":"N Engl J Med"},{"key":"5148_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","volume":"145","author":"DP Bella","year":"2022","unstructured":"Bella\u00a0DP, Baratto\u00a0F, Vergara\u00a0P et\u00a0al (2022) Does timing of ventricular tachycardia ablation affect prognosis in patients with an Implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 145:1829\u20131838. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059598","journal-title":"Circulation"},{"key":"5148_CR16","unstructured":"ClinicalTrials.gov (2016) Identifier NCT02830360, antiarrhythmics or ablation for ventricular tachycardia 2 (VANISH2). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02830360. Zugegriffen: 13. Okt. 2022"},{"key":"5148_CR17","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","volume":"21","author":"SJ Connolly","year":"2000","unstructured":"Connolly\u00a0SJ, Hallstrom\u00a0AP, Cappato\u00a0R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart\u00a0J 21:2071\u20132078. https:\/\/doi.org\/10.1053\/euhj.2000.2476","journal-title":"Eur Heart J"},{"key":"5148_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jacc.2022.06.035","volume":"80","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Wijnmaalen\u00a0AP, Ebert\u00a0M et\u00a0al (2022) Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia. J\u00a0Am Coll Cardiol 80:1045\u20131056. https:\/\/doi.org\/10.1016\/j.jacc.2022.06.035","journal-title":"J Am Coll Cardiol"},{"key":"5148_CR19","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","volume":"145","author":"R Tung","year":"2022","unstructured":"Tung\u00a0R, Xue\u00a0Y, Chen\u00a0M et al (2022) First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation 145:1839\u20131849. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060039","journal-title":"Circulation"},{"key":"5148_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","volume":"7","author":"Z Ling","year":"2014","unstructured":"Ling\u00a0Z, Liu\u00a0Z, Su\u00a0L et\u00a0al (2014) Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol 7:237\u2013243. https:\/\/doi.org\/10.1161\/CIRCEP.113.000805","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"5148_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacep.2015.04.005","volume":"1","author":"R Latchamsetty","year":"2015","unstructured":"Latchamsetty\u00a0R, Yokokawa\u00a0M, Morady\u00a0F et\u00a0al (2015) Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol 1:116\u2013123. https:\/\/doi.org\/10.1016\/j.jacep.2015.04.005","journal-title":"JACC Clin Electrophysiol"},{"key":"5148_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijcard.2013.09.008","volume":"169","author":"D Steven","year":"2013","unstructured":"Steven\u00a0D, Pott\u00a0C, Bittner\u00a0A et\u00a0al (2013) Idiopathic ventricular outflow tract arrhythmias from the great cardiac vein: challenges and risks of catheter ablation. Int J Cardiol 169:366\u2013370. https:\/\/doi.org\/10.1016\/j.ijcard.2013.09.008","journal-title":"Int J Cardiol"},{"key":"5148_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","volume":"7","author":"TS Baman","year":"2010","unstructured":"Baman\u00a0TS, Lange\u00a0DC, Ilg\u00a0KJ et\u00a0al (2010) Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 7:865\u2013869. https:\/\/doi.org\/10.1016\/j.hrthm.2010.03.036","journal-title":"Heart Rhythm"},{"key":"5148_CR24","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jacc.2012.06.035","volume":"60","author":"D Lakkireddy","year":"2012","unstructured":"Lakkireddy\u00a0D, Di Biase\u00a0L, Ryschon\u00a0K et\u00a0al (2012) Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J\u00a0Am Coll Cardiol 60:1531\u20131539. https:\/\/doi.org\/10.1016\/j.jacc.2012.06.035","journal-title":"J Am Coll Cardiol"},{"key":"5148_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"RE Knops","year":"2020","unstructured":"Knops\u00a0RE, Olde Nordkamp\u00a0LRA, Delnoy\u00a0P\u2011PHM et al (2020) Subcutaneous or transvenous defibrillator therapy. N\u00a0Engl J Med 383:526\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1915932","journal-title":"N Engl J Med"},{"key":"5148_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L K\u00f8ber","year":"2016","unstructured":"K\u00f8ber\u00a0L, Thune\u00a0JJ, Nielsen\u00a0JC et\u00a0al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N\u00a0Engl J Med 375:1221\u20131230. https:\/\/doi.org\/10.1056\/NEJMoa1608029","journal-title":"N Engl J Med"},{"key":"5148_CR27","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony\u00a0C, Jichi\u00a0F, Pavlou\u00a0M et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart\u00a0J 35:2010\u20132020. https:\/\/doi.org\/10.1093\/eurheartj\/eht439","journal-title":"Eur Heart J"},{"key":"5148_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","volume":"140","author":"K Wahbi","year":"2019","unstructured":"Wahbi\u00a0K, Yaou\u00a0BR, Gandjbakhch\u00a0E et al (2019) Development and validation of a\u00a0new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 140:293\u2013302. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039410","journal-title":"Circulation"},{"key":"5148_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/europace\/euab238","volume":"24","author":"A Mazzanti","year":"2022","unstructured":"Mazzanti\u00a0A, Trancuccio\u00a0A, Kukavica\u00a0D et al (2022) Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk). Europace 24:614\u2013619. https:\/\/doi.org\/10.1093\/europace\/euab238","journal-title":"Europace"},{"key":"5148_CR30","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","volume":"60","author":"P Chockalingam","year":"2012","unstructured":"Chockalingam\u00a0P, Crotti\u00a0L, Girardengo\u00a0G et al (2012) Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J\u00a0Am Coll Cardiol 60:2092\u20132099. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.046","journal-title":"J Am Coll Cardiol"},{"key":"5148_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","volume":"67","author":"A Mazzanti","year":"2016","unstructured":"Mazzanti\u00a0A, Maragna\u00a0R, Faragli\u00a0A et al (2016) Gene-specific therapy with mexiletine reduces Arrhythmic events in patients with long QT syndrome type 3. J\u00a0Am Coll Cardiol 67:1053\u20131058. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.033","journal-title":"J Am Coll Cardiol"},{"key":"5148_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1124\/dmd.115.065623","volume":"43","author":"MG McDonald","year":"2015","unstructured":"McDonald\u00a0MG, Au\u00a0NT, Rettie\u00a0AE (2015) P450-based drug-drug interactions of amiodarone and its metabolites: diversity of inhibitory mechanisms. Drug Metab Dispos 43:1661\u20131669. https:\/\/doi.org\/10.1124\/dmd.115.065623","journal-title":"Drug Metab Dispos"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-022-05148-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T20:48:24Z","timestamp":1675284504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-022-05148-0"}},"subtitle":["Was ist f\u00fcr die Praxis relevant?"],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["5148"],"URL":"https:\/\/doi.org\/10.1007\/s00059-022-05148-0","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"19 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Zeppenfeld: Biosense Webster (Forschung). L.\u00a0Eckardt: Abbott, Bayer, Boston Scientific, Daiichi Sankyo, Medtronic, Biotronik, Sanofi-Aventis, Bristol-Myers Squibb (Vortr\u00e4ge). H.\u00a0K\u00f6nemann und G.\u00a0Frommeyer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}